Greenbrook TMS Overview
Valuation check: GBNH's ROE is 37.67%, above the Healthcare sector average of 20.77%.
Get informed when a big investor buys or sells
+ Follow37.67%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GBNH is 37.67%. That is above the Healthcare sector average of 20.77%. Investors often review this figure alongside Greenbrook TMS's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, GBNH currently prints 37.67% for ROE, while the sector average sits near 20.77%. That is roughly 81.4% above the sector mean. Large gaps often invite a closer look at Greenbrook TMS's growth, margins, and balance sheet.
Return on Equity shows how effectively Greenbrook TMS converts resources into returns. At 37.67%, GBNH may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GBNH's ROE (37.67%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Greenbrook TMS's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
